Announcements Trials

Browse Landscape

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Sarcoma 2 Recurrence 2 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphoma 1 Liposarcoma 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Adrenocortical Carcinoma 1 Adenocarcinoma of Lung 1

Interventions

Trastuzumab 243 Paclitaxel 193 Cyclophosphamide 158 Docetaxel 134 Letrozole 113 Capecitabine 113 Fulvestrant 106 Doxorubicin 103 Bevacizumab 87 Carboplatin 81 exemestane 80 Anastrozole 79 Lapatinib 70 Tamoxifen 69 Albumin-Bound Paclitaxel 57 palbociclib 54 pertuzumab 53 Taxes 51 Gemcitabine 50 Radiotherapy 46 eribulin 43 pembrolizumab 41 Everolimus 41 Ado-Trastuzumab Emtansine 41 Vinorelbine 38 130-nm albumin-bound paclitaxel 35 ixabepilone 32 Epirubicin 28 pegfilgrastim 25 liposomal doxorubicin 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Breast Neoplasms × milademetan × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡